CurrentBlue Cross Blue Shield - MassachusettsPolicy 210

Biofeedback for Chronic Pain

This policy governs coverage of biofeedback treatments (including EMG biofeedback) for chronic pain for commercial members of Blue Cross Blue Shield — Massachusetts. It explains coverage stance, required authorization for inpatient services, coding considered investigational, and affected product lines.

Policy Summary

PayerBlue Cross Blue Shield - Massachusetts

PolicyBiofeedback for Chronic Pain

Policy CodePolicy 210

Change TypeNo material change

Effective Date

Next Review Date

Key ActionObtain precertification/preauthorization for these services when performed inpatient to avoid denial.

SourceLink

POLICY UPDATE CHANGES

No material clinical or coverage changes in this revision.

Investigationalcoverage stance for biofeedback (commercial)

Preauthorization requiredinpatient authorization

Not coveredoutpatient coverage

CPT/HCPCS listedcoding listed investigational

10-20typical session count

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

Coverage Determination

Investigational for chronic pain

Covered when ALL of the following are met:

Investigational determination: Biofeedback as a treatment of chronic pain (including but not limited to low back pain) is considered investigational for Commercial Members (Managed Care HMO/POS, PPO, and Indemnity).

Evidence from randomized controlled trials is inconsistent, often limited by small sample sizes and high dropout rates, and does not demonstrate durable or clinically significant benefit beyond sham or other conservative interventions.

For outpatient settings, biofeedback is not a covered service for Commercial Managed Care (HMO and POS) and for Commercial PPO and Indemnity; outpatient claims for these product lines are subject to denial if submitted for coverage.

The reference sections provided do not list any additional explicit coverage exclusions beyond the outpatient noncoverage noted for commercial product lines.

Available randomized controlled trials and systematic reviews are inconsistent and limited by small sample sizes and high dropout rates; some trials report transient or uncertain benefits while others show no advantage versus sham or other conservative interventions. Overall, the evidence is insufficient to determine that biofeedback improves net health outcome for chronic pain, which supports the policy determination of investigational status.

In the provided reference excerpts there are no explicit statements categorizing biofeedback as 'not medically necessary.' The policy classifies biofeedback for chronic pain as investigational based on insufficient evidence rather than as a formal 'not medically necessary' determination in these excerpts.

Coding and Billing

CPT codes considered investigational for chronic pain (Commercial Members)CPTNot Covered

90875	Individual psychophysiological therapy incorporating biofeedback training by any modality; approximately 20-30 minutes.
90876	Individual psychophysiological therapy incorporating biofeedback training by any modality; approximately 45-50 minutes.
90901	Biofeedback training by any modality.

HCPCS codes considered investigationalHCPCSNot Covered

E0746

Electromyography (EMG), biofeedback device.

Provider Responsibilities & Authorization

Prior Authorization

Prior Authorization Required for Inpatient Services

For services described in this policy, precertification/preauthorization IS REQUIRED for all products if the procedure is performed inpatient. Lack of precertification/preauthorization for inpatient services described in this policy may result in claim denial.

Applies to all products when procedure is performed inpatient
Obtain prior authorization before inpatient admission to avoid denial

Documentation Required

Coding and Documentation Guidance

Providers should report all services using the most up-to-date industry-standard procedure, revenue, and diagnosis codes, including modifiers where applicable. Inclusion or exclusion of a code in this policy does not guarantee member coverage or provider reimbursement; verify member benefits at the time of service.

Use current CPT, HCPCS, revenue, and ICD-10 codes

Prior Conservative Care

No conservative treatment requirements

No conservative treatment requirements are specified in these reference excerpts.

No conservative treatment requirements specified: The policy does not specify any required prior conservative therapies or stepwise treatment prerequisites for consideration of biofeedback in chronic pain within the provided excerpts.

Evidence compared biofeedback to other conservative interventions but did not show consistent benefit; policy classifies biofeedback as investigational rather than defining required prior treatments.

Definitions & Key Terms

Biofeedback — definition

DefinitionA technique that converts physiologic signals into outputs given to patients to teach self-regulation of involuntary physiologic processes.

Typical programCommonly delivered in 10–20 training sessions of about 30 minutes each (sessions may be up to 90 minutes).

ModalitiesUses various sensors (eg, electromyograph) and feedback types (visual, auditory) to present physiologic data to the patient.

Settings/providersMay be administered in outpatient settings by psychiatrists, psychologists, or general practitioners, individually or in groups and alone or with other behavioral therapies.

EMG biofeedback — definition

DefinitionBiofeedback using EMG monitoring intended to reduce muscle tension as a method to reduce chronic musculoskeletal or psychosomatic pain.

Frequency and Quantity Limits

Frequency limits

Frequency limitsNo frequency limits specified in the provided excerpts.

DocumentationPolicy excerpts do not define session counts as coverage thresholds; typical program descriptions are informational only (eg, 10–20 sessions).

Imaging/other requirementsNo imaging requirements or procedure-specific frequency caps are specified in the referenced sections.

Imaging and Diagnostic Requirements

Note

No imaging requirements specified

No imaging requirements are specified in the provided reference excerpts.

Background and Rationale

Biofeedback is a technique that converts physiologic signals into outputs presented to patients to teach self-regulation of involuntary physiologic processes. Electromyography (EMG) biofeedback monitors muscle activity (surface EMG/myofeedback) to train muscle control, relaxation, or functional movement and has been proposed for a range of conditions, including chronic musculoskeletal and psychosomatic pain.

Not Covered Services

Summary: For commercial members, outpatient biofeedback for chronic pain is classified as investigational and not a covered outpatient service for Managed Care (HMO and POS), PPO, and Indemnity product lines. The investigational classification is based on evidence that is inconsistent and insufficient to demonstrate durable or clinically meaningful benefit.